14630269

Source:http://linkedlifedata.com/resource/pubmed/id/14630269

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0017262, umls-concept:C0029005, umls-concept:C0069515, umls-concept:C0185117, umls-concept:C0279626, umls-concept:C0439849, umls-concept:C0445223, umls-concept:C1552599, umls-concept:C1704787, umls-concept:C1704824, umls-concept:C2911684
pubmed:issue	5
pubmed:dateCreated	2003-11-21
pubmed:abstractText	Esophageal carcinoma is a challenging target for radiotherapy. To improve treatment efficacy, an investigation of a predictive factor is desirable. In this study, we evaluated the significance of apoptosis and immunohistochemical staining for p53, Ki-67, c-erbB-2 (HER-2/neu), Ku (p70/p80), and DNA-PKcs for predictive markers of the responsiveness to chemoradiotherapy in esophageal squamous cell carcinoma.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/7603616
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antigens, Nuclear, http://linkedlifedata.com/resource/pubmed/chemical/CIB1 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Calcium-Binding Proteins, http://linkedlifedata.com/resource/pubmed/chemical/DNA Helicases, http://linkedlifedata.com/resource/pubmed/chemical/DNA-Binding Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Ki-67 Antigen, http://linkedlifedata.com/resource/pubmed/chemical/Ku autoantigen, http://linkedlifedata.com/resource/pubmed/chemical/Receptor, erbB-2, http://linkedlifedata.com/resource/pubmed/chemical/Tumor Suppressor Protein p53, http://linkedlifedata.com/resource/pubmed/chemical/XRCC5 protein, human
pubmed:status	MEDLINE
pubmed:month	Dec
pubmed:issn	0360-3016
pubmed:author	pubmed-author:AkamatsuMasayukiM, pubmed-author:KajiyamaYoshiakiY, pubmed-author:MatsumotoToshiharuT, pubmed-author:OkaKuniyukiK, pubmed-author:SasaiKeisukeK, pubmed-author:SonoueHiroshiH, pubmed-author:TsurumaruMasahikoM, pubmed-author:YamasakiShigetakaS
pubmed:issnType	Print
pubmed:day	1
pubmed:volume	57
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1323-7
pubmed:dateRevised	2009-11-19
pubmed:meshHeading	pubmed-meshheading:14630269-Adult, pubmed-meshheading:14630269-Aged, pubmed-meshheading:14630269-Aged, 80 and over, pubmed-meshheading:14630269-Antigens, Nuclear, pubmed-meshheading:14630269-Apoptosis, pubmed-meshheading:14630269-Calcium-Binding Proteins, pubmed-meshheading:14630269-Carcinoma, Squamous Cell, pubmed-meshheading:14630269-DNA Helicases, pubmed-meshheading:14630269-DNA-Binding Proteins, pubmed-meshheading:14630269-Drug Resistance, Neoplasm, pubmed-meshheading:14630269-Esophageal Neoplasms, pubmed-meshheading:14630269-Female, pubmed-meshheading:14630269-Humans, pubmed-meshheading:14630269-Ki-67 Antigen, pubmed-meshheading:14630269-Male, pubmed-meshheading:14630269-Middle Aged, pubmed-meshheading:14630269-Radiation Tolerance, pubmed-meshheading:14630269-Radiotherapy Dosage, pubmed-meshheading:14630269-Receptor, erbB-2, pubmed-meshheading:14630269-Retrospective Studies, pubmed-meshheading:14630269-Tumor Suppressor Protein p53
pubmed:year	2003
pubmed:articleTitle	c-erbB-2 oncoprotein expression related to chemoradioresistance in esophageal squamous cell carcinoma.
pubmed:affiliation	Department of Radiology, Juntendo University School of Medicine, Tokyo, Japan.
pubmed:publicationType	Journal Article, Research Support, Non-U.S. Gov't